Answer
Decreased bone mineral density, osteopenia, osteoporosis and fractures have been reported with long-term phenobarbital sodium therapy; the mechanism affecting bone metabolism has not been identified.
Sources for this answer
- Phenobarbital Sodium 30mg/ml InjectionMartindale Pharma, an Ethypharm Group Company · emc · SmPC §4.8 Undesirable effects · Version 5Document updated
Sources checked